NO965507L - Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer - Google Patents

Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer

Info

Publication number
NO965507L
NO965507L NO965507A NO965507A NO965507L NO 965507 L NO965507 L NO 965507L NO 965507 A NO965507 A NO 965507A NO 965507 A NO965507 A NO 965507A NO 965507 L NO965507 L NO 965507L
Authority
NO
Norway
Prior art keywords
prolactin
profile
human
determining
subject
Prior art date
Application number
NO965507A
Other languages
English (en)
Other versions
NO965507D0 (no
Inventor
Anthony H Cincotta
Albert H Meier
Original Assignee
Ergo Science Inc
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ergo Science Inc, Univ Louisiana State filed Critical Ergo Science Inc
Publication of NO965507D0 publication Critical patent/NO965507D0/no
Publication of NO965507L publication Critical patent/NO965507L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Control Of Transmission Device (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Det beskrives fremgangsnåte for påvisning og Justering av abnormiteter 1 prolaktlndagllge ryttner. Det beskrives en fremgangsmåte son saimienllgner en prolaktlnprofll fra et vertebratsubjekt med prolaktlnprofllen fra andre vertebratsub]ekter san har en normal prolaktlnprofll; og Justering av prolaktlnprofllen 1 subjektet for å sørge for at profilen 1 subjektet tilpasser seg (eller tilnærmer seg) den normale prolaktlnprofllen. Det ble også beskrevet en fresngangsmåte for evaluering av daglig prolaktlnprofll i et menneske der metoden skaffer tilveie sanmenllgning av et sett av minst to prolaktin-nlvåer fra menneske og saitmenlIgner disse med tilsvarende prolaktin-nivåer fra friske mennesker (eller en forhåndsetablert gjennomsnittlig prolaktinkurve for friske mennesker) ved sanine tidspunkter. Metoden tilveiebringer også bestenmelse av on et menneske har en abnorm prolaktlnprofll.
NO965507A 1994-06-23 1996-12-20 Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer NO965507L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26455894A 1994-06-23 1994-06-23
PCT/US1995/009061 WO1996000396A1 (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms

Publications (2)

Publication Number Publication Date
NO965507D0 NO965507D0 (no) 1996-12-20
NO965507L true NO965507L (no) 1997-02-11

Family

ID=23006606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965507A NO965507L (no) 1994-06-23 1996-12-20 Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer

Country Status (14)

Country Link
EP (1) EP0769148A1 (no)
JP (1) JPH10503842A (no)
AU (1) AU3101395A (no)
BR (1) BR9508366A (no)
CA (1) CA2192855A1 (no)
CZ (1) CZ378796A3 (no)
FI (1) FI965146A (no)
HU (1) HUT76976A (no)
IL (1) IL114300A0 (no)
MX (1) MX9700225A (no)
NO (1) NO965507L (no)
SK (1) SK167396A3 (no)
WO (1) WO1996000396A1 (no)
ZA (1) ZA955192B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
EP3524248A1 (en) 2007-06-21 2019-08-14 VeroScience LLC Method of treating metabolic disorders and depression with dopamine receptor agonists
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
US5066526A (en) * 1987-11-19 1991-11-19 Exxon Chemical Patents Inc. Thermoplastic films for use in stretch/cling applications
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Also Published As

Publication number Publication date
HUT76976A (hu) 1998-01-28
JPH10503842A (ja) 1998-04-07
FI965146A0 (fi) 1996-12-20
BR9508366A (pt) 1997-09-30
CA2192855A1 (en) 1996-01-04
SK167396A3 (en) 1997-11-05
EP0769148A1 (en) 1997-04-23
NO965507D0 (no) 1996-12-20
WO1996000396A1 (en) 1996-01-04
FI965146A (fi) 1996-12-20
HU9603543D0 (en) 1997-02-28
AU3101395A (en) 1996-01-19
ZA955192B (en) 1996-05-07
IL114300A0 (en) 1995-10-31
CZ378796A3 (en) 1997-09-17
MX9700225A (es) 1997-04-30

Similar Documents

Publication Publication Date Title
MY131392A (en) Improved methods for the determination and adjustment of prolactin daily rhythms
Li et al. A critical evaluation of heart rate monitoring to assess energy expenditure in individuals
Abbink et al. Detection of onset and termination of muscle activity in surface electromyograms
Freedman et al. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring
Pigozzi et al. Effects of aerobic exercise training on 24 hr profile of heart rate variability in female athletes
Tramontano et al. Maintaining gait stability during dual walking task: effects of age and neurological disorders
Gallet et al. The significance threshold for coherence when using the Welch's periodogram method: Effect of overlapping segments
CA2284553A1 (en) Method for diagnosing psychiatric disorders
Friel et al. Variability of ethanol absorption and breath concentrations during a large‐scale alcohol administration study
HSU et al. Decreased chewing activity during mouth breathing
Devlin et al. Bite force and masseter muscle electromyographic activity during onset of an isometric clench in man
NO965507L (no) Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer
Janshen et al. Muscle synergies in patients with multiple sclerosis reveal demand-specific alterations in the modular organization of locomotion
Mezzacappa et al. Tricyclic antidepressants and cardiac autonomic control in children and adolescents
WO1995022278A3 (en) Automated system and method for determining pupillary threshold response
Jenkins et al. Reye's syndrome: assessment of intracranial monitoring.
WO2004056271A3 (en) Method for determining normal measurements for a patient
Bechtold Indian adolescent suicide: clinical and developmental considerations.
AU4127396A (en) Diagnostic method for inflammatory conditions in the intestines
Corso Support for Corso's hearing loss model relating aging and noise exposure
Partonen et al. Suppression of melatonin secretion by bright light in seasonal affective disorder
Sun et al. Autonomic nervous control of heart rate during blood-flow restricted exercise in man
Gohara et al. Heart rate variability change induced by the mental stress: the effect of accumulated fatigue
Lee A note on the comparison of group means based on repeated measurements of the same subject
Bazelmans et al. The chronic fatigue syndrome and hyperventilation